Active Human and Porcine Serum Induce Competence for Genetic Transformation Streptococcus suis

A recent scientific article has been published by the Host-Microbe-Interactions group at WUR on competence development for genetic transformation in the emerging zoonotic pathogen Streptococcus suis.

 

 

read more
Profile of Dr. Manouk Vrieling, WP leader of WP4 in the PIGSs project

 has been working at our institute for almost 2 years now: 'I study the interaction between bacteria and the host immune system in order to find new strategies to prevent diseases in livestock. For example, I’m working on vaccine development for Streptococcus suis. This bacterium is a common cause of serious illness such as meningitis in piglets. A vaccine would mean fewer infections, better animal welfare and less use of antibiotics.'

read more
Great paper: Comparative Virulence and Genomic Analysis of Streptococcus suis Isolates

A newly published report by Prof. Tracy Nicholson et al of the National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, provides a framework for future allelic replacement and/or functional genomic studies investigating genetic characteristics underlying the spectrum of disease outcomes caused by Streptococcus suis isolates.

read more
Interesting paper from the Hannover group on bordetella bronchiseptica promoting adherence, colonization, and cytotoxicity of Streptococcus suis in a porcine precision-cut lung slice model

Bordetella (B.) bronchiseptica and Streptococcus (S.) suis are major pathogens in pigs, which are frequently isolated from co-infections in the respiratory tract and contribute to the porcine respiratory disease complex (PRDC). Despite the high impact of co-infections on respiratory diseases of swine (and other hosts), very little is known about pathogen-pathogen-host interactions and the mechanisms of pathogenesis.

read more
Great paper on the ability of Streptococcus suis to genetically transform when cultured in active porcine and human serum.

The Wageningen University & Research group recently published ((Ferrando et al) in Pathogens about the competence of Streptococcus suis, an important zoonotic agent and porcine pathogen, for genetic transformation with plasmid or linear DNA when cultured in active porcine and human serum.

read more
Nice front cover page of our new COX-2 paper on results obtained within the PIGSs project

A figure in a recent paper published by the University of Veterinary Medicine Hannover based on work conducted in the PIGSs project was selected as cover page in Microorganisms, an open-access journal from MDPI. 

read more
Over 30 presentations on S. suis during the two-day online scientific PIGSs meeting on 23-25 Febr 2021.

Over 30 presentations on Streptococcus suis GWAS studies, virulence mechanisms, next generation probiotics, viral co-infections, risk factors & disease burden during the two-day online scientific PIGSs meeting on 23-25 Febr.

read more
Estimation of the economic cost of S. suis in Spain, Germany and the Netherlands

On January 28th 2021,  Carlos Neila (IRTA) gave a presentation on “Estimation of the economic cost of S. suis in Spain, Germany and the Netherlands”, work conducted in work package 5 of the PIGSs project. 

read more
Impact story: New vaccine against Streptococcus suis in the making

Wageningen University Research published this week an impact story on the PIGSs project: "New vaccine against Streptococcus suis in the making". 

read more
Wageningen Bioveterinary Research participates in an EU collaboration for developing vaccine adjuvants

Researchers from Wageningen Bioveterinary Research, partner in the PIGSs project, participate in a European Network of Vaccine Adjuvants (ENOVA), which brings together European experts and stakeholders working in different areas of adjuvant and vaccine research and development, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.

read more